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EVALUACIÓN GLOBAL SUBJETIVA DEL ESTADO
DE NUTRICIÓN GENERADA POR EL PACIENTE,
ALBÚMINA Y TRANSFERRINA EN PACIENTES CON
CÁNCER DE CABEZA O CUELLO ALIMENTADOS POR
GASTROSTOMÍA
Resumen
Introducción: Los pacientes con cáncer de cabeza o cuello
alimentados por gastrostomía tienen a menudo una deterio -
ración en la capacidad de hablar. Con frecuencia para la evalua-
ción nutricional se usan parámetros bioquímicos y antropomé-
tricos.
Objetivos: Evaluación Global Subjetiva – Generada por el
Paciente (EGS-GP): (1) aplicabilidad; (2) el estado nutricional
del paciente; (3) la asociación con los valores de albúmina y
transferrina séricas.
Métodos: Evaluación nutricional (EGS-GP), albúmina y
transferrina en pacientes ambulatorios adultos con cáncer,
sometidos a alimentación prolongada (> 1 mes) por gastros-
tomía. Valoración realizada en la misma consulta. 
Resultados: La EGS-GP fue fácilmente factible en 42
pacientes, incluso en pacientes con dificultades en hablar. Vein-
ticinco estaban con desnutrición moderada/severa (EGS-
GP/B+C). En 41 la EGS-GP fue ≥ 2, demostrando la necesidad
de intervención nutricional/farmacológica. La albúmina estaba
por debajo de lo normal en 13 pacientes. La transferrina en 19
pacientes. La media de albúmina y transferrina de los pacientes
moderadamente/severamente desnutridos (EGS-GP/B+C) fue
significativamente más baja, en comparación con los bien
nutridos (EGS-GP/A). Se ha hallado asociación entre la EGS-
GP, la albúmina y transferrina. 
Conclusiones: En los pacientes con cáncer de cabeza o cuello
alimentados por gastrostomía, la EGS-GP fue viable y útil,
incluso en los pacientes con dificultades de comunicación. La
mayoría muestran desnutrición moderada/severa (EGS-
GP/B+C). La EGS-GP ha calificado 41 pacientes como requi-
riendo de intervención nutricional/farmacológica. La EGS-GP
debe incluirse sistemáticamente en la valoración de estos
pacientes. En estos, la albúmina y transferrina mostraron una
relación con la EGS-GP y deben ser consideradas como biomar-
cadores nutricionales.
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Abstract
Introduction: Gastrostomy fed head or neck cancer patients
frequently have impaired speech capacities. Enteral feeding
teams frequently depend on laboratorial or anthropometrical
parameters for nutritional assessment. 
Aims: In these patients, this study aimed to evaluate: (1) the
practicability of Scored - Patient-Generated Subjective Global
Assessment (PG-SGA); (2) their nutritional status using the
Scored-PG-SGA; (3) association of serum albumin and transfe-
rrin values to the nutritional status rating using PG-SGA.
Methods: On adult outpatients with head or neck cancer
under prolonged (> 1 month) gastrostomy feeding, Scored-PG-
SGA, albumin and transferrin were evaluated during the same
appointment.
Results: Scored-PG-SGA was easily feasible in 42 patients,
even in patients with speech difficulties. Twenty-five patients
were moderately/severely undernourished (PG-SGA/B+C).
Scored-PG-SGA rated 41 patients as ≥ 2, thus needing nutri-
tional/pharmacologic intervention. Albumin was low in 13
patients. Transferrin was low in 19 patients. Average albumin
and transferrin in moderately/severely undernourished
patients (PG-SGA/B+C) was significantly lower than in well-
nourished (PG-SGA/A). There was association between Scored-
PG-SGA rating, albumin and transferrin. 
Conclusions: In PEG fed head or neck cancer patients, PG-
SGA was practicable and useful, even in patients with impaired
speaking skills. Most patients displayed moderate/severe
malnutrition (PG-SGA/B+C). Scored-PG-SGA rated 41
patients as needing for nutritional/pharmacological interven-
tion. Scored-PG-SGA should be systematically included in the
evaluation of these patients. In these patients, albumin and
transferrin levels showed relation with Scored-PG-SGA and
should be considered as nutritional biomarkers. 
(Nutr Hosp. 2014;29:420-426)
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Introduction
Malnutrition is a major issue in patients with head or
neck cancer including cervical esophageal cancer, due
to the direct effects of the disease, therapy side effects
and poor food intake1-3. This condition affects the
response to the cancer treatment and increases suscep-
tibility to its side effects. Malnutrition is associated
with an increase in number and severity of complica-
tions, impaired quality of life and decreased survival
rate3-5. In these patients, chewing and swallowing may
be affected by the cancer mass position, and by cancer
therapy, reduced food intake thus contributing to
weight loss and malnutrition6,7. 
In dysphagic patients, the Percutaneous Endoscopic
Gastrostomy (PEG) is the preferred nutritional access
method for prolonged enteral nutrition, to prevent
weight loss and maintain or improve patients’ nutritional
status1,5,8. In this setting, it’s essential to use nutritional
assessment tools that prove to be practical and trust-
worthy. Gastrostomy fed head or neck cancer patients
frequently have speech difficulties and are difficult to
assess. Often, enteral feeding teams rely on objective
data, as anthropometric and laboratory data, to evaluate
the nutritional status of gastrostomy fed patients1,9,10. 
Lab tools commonly used (albumin, transthyretin
and transferrin) are known as prognosis, inflammatory
and nutritional status biomarkers, even though they are
influenced by several factors11-14. These biomarkers are
frequently used to assess patients’ nutritional status as
they are widespread, easy to obtain and have a low
cost11-15. These proteins can be used as malnutrition
biomarkers in patients with no inflammatory condition
or with a known mild chronic inflammatory condi-
tion12. Serum proteins are neither specific nor sensitive
nutritional status indicators but they can be used with
other nutritional assessment tools in cancer patients12.
The Patient-Generated Subjective Global Assess-
ment (PG-SGA) is a specific method to assess the nutri-
tional status of both cancer inpatients and outpatients16-
18
. This tool puts the patient in one of three categories:
A) Well-nourished or anabolic, B) Suspected or
moderate undernutrition, C) Severely undernour-
ished3,16. Using the Scored-PG-SGA, besides getting
those three nutritional status categories, the healthcare
professional obtains an individual score for each patient.
These score results allow the healthcare professio nal to
select priority patients for nutritional support2,3,16,18. The
Scored PG-SGA is the standard method to assess cancer
patients’ nutritional status, as recommended by the
Oncology Nutrition Dietetic Practice Group, of the
American Dietetic Association18,19.
Several studies have shown that the PG-SGA score
and the serum albumin are accurate for predicting the
global result of the Subjective Global Assessment
(SGA), being useful to differentiate between undernou -
rished and well-nourished cancer patients. Patients rated
as undernourished (PG-SGA B+C) showed lower serum
albumin levels and a higher average PG-SGA score
when compared to those rated as well-nourished (PG-
SGA A)20-22. Other authors who used PG-SGA have
concluded that cancer patients diagnosed as moderately
or severely undernourished (PG-SGA B+C) presented
significantly lower body weight, Body Mass Index
(BMI), total lymphocyte count, transferrin, transthyretin
(pre-albumin) and albumin, proving that the nutritional
status assessment using PG-SGA was associated with
laboratorial/anthropometric data from these patients23-25.
Gastrostomy fed patients suffering from head or
neck cancer frequently have speaking difficulties, as
the same lesions that cause dysphagia also disturb
speaking abilities1. To the best of our knowledge, there
are no previous systematic studies evaluating PEG-
patients using PG-SGA. The present study aimed to
assess the nutritional status of head or neck cancer
patients subjected to PEG-feeding, by using the Scored
PG-SGA. The specific goals were: (1) to evaluate the
practicability of the Scored PG-SGA in these patients;
(2) to test the hypothesis that the nutritional status
rating using the PG- SGA tool was associated with the
serum albumin and transferrin values in these patients. 
Patients and Methods
Study Design
A descriptive-correlational observational study was
designed, to be undertaken in a hospital setting. This
project was approved by the Ethic Committee of our
Hospital.
Patients
The sample consists of adult outpatients with head or
neck cancer subject to prolonged enteral feeding by
gastrostomy, who attended a medical appointment at
the Artificial Feeding Team of our hospital.
Adult outpatients (age ≥ 18), from both genders, who
were diagnosed with head or neck cancer (including
cervical esophagus cancer) under enteral feeding by
gastrostomy for over a month were recruited for the
study, from December 2012 to May 2013. Exclusion
criteria were: 
1. Refusal to participate the study
2. PEG-feeding during less than one month
3. Terminal cancer
4. Other cachexia-inducing diseases
5. Mental or neurological illness 
6. Kidney or liver disorders
Nutritional Assessment Tool
We used the Portuguese version of the Scored
Patient-Generated Subjective Global Assessment
PG-SGA, albumin and transferrin
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(Scored PG-SGA) survey, validated specifically for
cancer inpatients and outpatients16,17.
The first section of the survey, that covers the data
related to their medical history, was filled by the
patient, or, if they were illiterate, by the researcher.
This first section includes the register of 1) weight
change; 2) dietary intake change; 3) cancer-related
nutrition impact symptoms; 4) functional capacity4,16.
Their current body weight (in Kg) was obtained using a
calibrated digital KERN® MPS (200 ± 0,1 kg) scale.
Most patients were weighed in the upright position,
using only underclothes. Patients with poor functional
capacity were weighed sitting down in a digital SECA®
(200 ± 0,1 kg) scale-chair. Weight was measured in
kilograms, rounded to one decimal place, with an
observational error of 0,05 kg. The patient’s weight
from a month ago was obtained from his medical file.
Body height was measured in the orthostatic position,
in meters and rounded to the centimeter, with an obser-
vational error of 0,05 cm.
The remaining questions, in the second section, were
filled in by the main researcher, based on the patient’s
medical file and a physical examination. This section
incorporated data pertaining to the patient’s age, type
of cancer, disease stage, metabolic stress increase-
related components and physical examination4,16. Each
of the survey’s questions is scored, and, at the end, a
total PG-SGA score is obtained16. Scoring 9 or above
indicates a critical need for nutritional intervention
and/or symptom management.
At the end of the survey, the patient is rated nutri-
tionally in one of three categories: “Well-nourished or
anabolic” (PG-SGA - A), “Moderately or suspected of
being undernourished” (PG-SGA B) and “Severely
undernourished” (PG-SGA C)16. 
Research Method
Each patient was nutritionally assessed in a single
moment, using the Scored PG-SGA survey. In the
same assessment day, a blood sample was collected for
serum albumin and transferrin evaluation. According
to the reference normal values used by the hospital
laboratory (albumin: 3,5-5,0 g/dl; transferrin: 200-360
mg/dl)26, serum albumin values were considered
“normal” when above or equal to 3,5 g/dl, and “low”
when under 3,5 g/dl27,28. Serum transferrin values were
considered “normal” when above or equal to 200 mg/dl
and “low” when under 200 mg/dl28.
Statistical analysis
All data was analyzed with the SPSS® software
(version 17.0). Descriptive and inferential statistics
were used. Nominal measurement scales were used for
PG-SGA, to rate patients in one of the two desired
nutritional status categories (PG-SGA-A or PG-SGA
B+C). Serum albumin and transferrin values were
considered as either “normal” or “low”, according to
the reference values for normality. A chi-square test
was used to test the hypothesis of the nutritional status
rating using PG-SGA being related with the serum
albumin and transferrin values. The independent
sample t-test was used to determine if there were statis-
tically significant differences in the means of the
continuous quantitative variables of the patients rated
as PG-SGA A and PG-SGA B+C. Statistical signifi-
cance was reported at the conventional α = 0,05 level.
Results
Patient Characteristics
We evaluated 42 head or neck cancer patients, 38
men (90,5%) and 4 women (9,5%), with ages ranging
between 47 and 87 years (average: 63,12 ± 8,8 years;
median: 63 years). Overall, 14 patients were diagnosed
with pharynx cancer (33,3%), 11 with mouth cancer
(26,2%), 8 with larynx cancer (19%), 6 with cervical
metastases that compromise swallowing (14,3%) and 3
with upper esophageal cancer (7,1%). All patients had
advanced cancer, 12 patients (28,6%) had stage III and
30 (71,4%) had stage IV cancer. Looking at the cancer
treatment each patient underwent before the study, 21
(50%) underwent surgery, 22 (52,4%) underwent radio-
therapy, and all patients underwent chemotherapy. PEG
procedure was performed one month before the study in
21 patients (50%), 3 months before in 11 (26,2%) and 6
months before in 10 patients (23,8%) (Table I). 
Scored Patient - Generated Subjective Global
Assessment survey in nutritional evaluation
PG-SGA feasibility
The PG-SGA was easily feasible, with all items being
evaluated even in patients with speech difficulties.
Nutritional status rating
Using the Scored PG-SGA, 25 patients (59,5%)
were shown to be moderately or severely undernou -
rished (PG-SGA B+C) and 17 were well-nourished
(PG-SGA A) (Table I ; Table II).
Body weight changes during one month
When looking at unintentional body weight loss, 21
(50%) out of the 42 assessed patients had lost weight in
the month earlier to the survey filling, 13 (31%) had
gained weight and 8 (19%) had maintained their body
weight. 
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By analyzing the patient’s weight loss percentage in
the previous month, 26,2% had a weight loss of ≤ 5%,
suggesting risk of or moderate undernourishment, and
23,8% had lost > 5% of their total body weight, which
suggests severe undernourishment (Table I).
The weight loss percentage in the month that
preceded the assessment varied between 0% and 10%
of lost weight, with an average 2,5 ± 3,1%. Well-nour-
ished patients (PG-SGA A) had an average lost weight
percentage of 0,4 ± 0,9%, while those with suspected
or moderate undernourishment (PG-SGA B) lost, in
average, 3,5 ± 3,1% and those severely undernourished
(PG-SGA C) had a weight loss average of 5,3 ± 3,6%
(Table II).
Food Intake during the past month
In the “Food Intake” section, all patients confirmed
they were PEG-fed. Three of them (7,1%) claimed to
also ingest some food orally. Nevertheless, most of
their feeding was through the PEG tube and the oral
intake only “for pleasure”. Oral ingestion was not
taken into account when providing for the patients’
nutritional needs. Even so, 11 patients (26,2%)
displayed psychological resistance to this method of
feeding, even though they were unable to eat through
any other method.
Prevalence of nutrition impact symptoms
Evaluating the presence of typical cancer patients’
symptoms that affect food ingestion or nutrient absorp-
tion, 16 patients (38,1%) presented nutritionally signi -
ficant symptoms (Table III). The remaining 26 patients
(61,9%) didn’t present symptoms that prevented tube
feeding.
Functional capacity during the past month
Evaluating the functional capacity during the last
month before the study, 6 patients (14,3%) said they
had normal activities with no limitations, 11 (26,2%)
said they did not have normal activities, but were able
to stand up and perform mild normal activities, 8
(19%), said they were not able to perform most activi-
ties, although they were in bed or sitting less than half
the day, 11 (26,2%) claimed to be able to do little
activity and to spend most of the day in bed or on a
chair and 6 (14,3%) were mostly bedridden, rarely
Table I
Characteristics of cancer patients undergoing enteral
nutrition by gastrostomy
Sample N = 42
Gender (men/women)b 38/4 (90,5/9,5)
Age (years) a 63,12 ± 8,8
Diagnosis b
Pharynx cancers 14 (33,3)
Mouth cancers 11 (26,2)
Larynx cancers 8 (19)
Cervical metastasis 6 (14,3)
Cervical oesophagus cancers 3 (7,1)
Tumour stageb
III 12 (28,6)
IV 30 (71,4)
Treatment methodb
Surgery 21 (50)
Radiotherapy 22 (52,4)
Quimiotherapy 42 (100)
Gastrostomy timeb
1 month 21 (50)
3 months 11 (26,2)
6 months 10 (23,8)
PG-SGA rating c
A: Well-nourished 17 (40,5)
B: Moderately undernourished 19 (45,2)
C: Severely undernourished 6 (14,3)
Body weight changeb
Lost 21 (50)
Increased 13 (31)
Maintained 8 (19)
Percentage of weight lossb
≤ 5% 11 (26,2)
> 5% 10 (23,8)
aaverage ± SD.
bFrequency (percentage).
cPatient – Generated Subjective Global Assessment.
Table II
Patient - Generated Subjective Global Assessment (PG-SGA), total PG-SGA score and weight loss percentage
in the previous month in gastrostomy-fed cancer patients
Well-nourishedc Undernourishedc
Sample PG-SGA Ab PG-SGA Bb PG-SGA Cb
Patients (%) 42 (100) 17 (40,5) 19 (45,2) 6 (14,3)
% Weight loss a 2,5 (±3,1) 0,4 (±0,9) 3,5 (±3,1) 5,3 (±3,6)
PG-SGA scorea 7,4 (± 4,0) 3,9 (±2,1) 8,7(±2,5) 12,8 (±3,8)
aaverage ± SD.
bPatient-Generated Subjective Global Assessment.
cPG-SGA rating in A (Well-nourished) and B+C (moderately/severely undernourished).
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being out of bed. Most patients showed some mild
functional deficit during the month before the study, 8
(19%) showed a moderate functional deficit and 17
(40,5%) a severe functional deficit.
Total PG-SGA Score 
The average total PG-SGA score was 7,4 ± 4,0
points (median: 7 points), ranging between 1 and 17
points. Well-nourished patients (PG-SGA A) had an
average PG-SGA total score of 3,9 ± 2,1 points, those
suspected of or moderately undernourished (PG-SGA
B), 8,7 ± 2,5 points and those severely undernourished
had an average score of 12,8 ± 3,8 points (Table II).
According to the total PG-SGA score, 41 patients
needed an appropriate nutritional or pharmacologic
intervention. 
Nutritional assessment rating, albumin
and transferrin: how they’re related
The range of serum albumin levels was 2,5-5,0 g/dl
(normal 3,5-5,0 g/dl). The average serum albumin
levels were 3,9 ± 0,7 g/dl (Table IV). The serum
albumin levels were low (< 3,5 g/dl) in 13 patients
(31%) and within the reference range for normality in
29 patients (69%). Out of the 17 patients rated as well-
nourished, 16 (94,1%) presented normal serum albumin
levels and 1 (5,9%) a low serum albumin level. Out of
the 25 patients rated as moderately or severely under-
nourished, 13 (52%) presented normal serum albumin
levels and 12 (48%) low serum albumin levels.
In well-nourished patients (PG-SGA A) the average
serum albumin level was 4,4 ± 0,4 g/dl (range: 3,3-5,0
g/dl), in patients with suspected or moderate undernutri-
tion (PG-SGA B) 3,7 ± 0,5 mg/dl (range: 2,8-4,3 g/dl)
and in severely undernourished patients (PG-SGA C)
3,1 ± 0,6 mg/dl (range: 2,5-3,8 g/dl). Statistically signif-
icant differences were found between the average
serum albumin level in well-nourished patients (PG-
SGA - A) and moderately or severely undernourished
patients (PG-SGA B+C) (p< 0.001) (Table IV).
An association was found between the nutritional
status rating using the PG-SGA tool and the serum
albumin levels in these cancer patients subject to
prolonged PEG-feeding (p = 0,011).
The range of serum transferrin levels was 95-325
mg/dl (normal: 200-360 mg/dl). The average serum
transferrin levels were 204,95 ± 54,5 mg/dl (Table IV).
The serum transferrin levels were low (< 200 mg/dl) in
19 patients (45,2%) and within the reference range for
normality in 23 patients (54,8%). Out of the 17 patients
rated as well-nourished, 14 (82,4%) presented normal
serum transferrin levels and 3 (17,6%) low serum
transferrin levels. Out of the 25 patients rated as
moderately or severely undernourished, 9 (36%)
presented normal serum transferrin levels and 16
(64%) low serum transferrin levels.
In well-nourished patients (PG-SGA A) the average
serum transferrin level was 241,2 ± 46,5 mg/dl (range:
140-325 mg/dl) in patients with suspected or moderate
undernutrition (PG-SGA B) 185,6 ± 46,7 mg/dl (range:
95-266 mg/dl) and in severely undernourished patients
(PG-SGA C) was 163,3 ± 39,9 mg/dl (range: 100-222
mg/dl). Statistically significant differences were found
between the average serum transferrin levels in well-
nourished patients (PG-SGA A) and in moderately or
severely undernourished patients (PG-SGA B+C) (p <
0.001) (Table IV).
An association was found between the nutritional
status rating using the PG-SGA tool and the serum
transferrin of cancer patients subject to prolonged
enteral feeding by gastrostomy (p = 0,008).
Table III
Nutrition impact symptoms showed by
gastrostomy-fed cancer patients
Symptoms n = 16 (100)a
Constipation 9 (56,3)
No appetite 7 (43,8)
Feel full quickly 3 (18,8)
Nausea 2 (12,5)
Vomiting 2 (12,5)
Diarrhea 1 (6,3)
Smells bother me 1 (6,3)
aFrequency (percentage).
Table IV
Nutritional status PG-SGAb rating, average serum albumin and transferrin in gastrostomy cancer patients
Well-nourishedc Undernourishedc
Serum proteins Sample (n = 42) PG-SGA Ab PG-SGA Bb PG-SGA Cb p valued
Albumin (g/dl)a 3,9 (± 0,7) 4,4 (± 0,4) 3,7(± 0,5) 3,1 (± 0,6) p < 0.001
Transferrin (mg/dl)a 204,95 (± 54,5) 241,2 (± 46,5) 185,6 (± 46,7) 163,3 (± 39,9) p < 0.001
aaverage ± SD.
bPatient – Generated Subjective Global Assessment.
cPG-SGA rating in A (Well-nourished) and B+C (moderately/severely undernourished).
dStudent T test to test differences between average serum albumin and transferrin in well-nourished (PG-SGA A) and moderately/severely under-
nourished patients (PG-SGA B+C) (p ≤ 0,05). 
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Discussion
The PG-SGA tool had already been used on patients
with different types of cancer, but no other studies
evaluated the use of the PG-SGA in head or neck
cancer patients needing a gastrostomy for enteral
feeding16,18,29,24. Our study proved that PG-SGA is a
feasible and easily usable tool to assess the nutritional
status of head or neck gastrostomized cancer patients,
even in those whose tumor location or treatments
caused speech difficulties16,24,25.
Using the PG-SGA nutritional assessment, it is clear
that undernutrition had very high prevalence in our
patients, with 59,5% of the patients being moderately
or severely undernourished (PG-SGA B+C). This
result is in accordance with the undernutrition preva-
lence mentioned by other authors (40-80%) found in
cancer patients2-4,16. The moderately or severely under-
nourished patient’s prevalence was higher than the one
found by other authors (43,8%) in patients with head or
neck cancers but not subject to PEG-feeding29.
The percentage of patients that lost body weight invo-
luntarily in the month before the nutritional assessment
was very high. Twenty-one patients were shown to have
lost weight, with 10 of them having lost more than 5% of
their body weight, which is considered a significant
unintentional weight loss in a month30. This pronounced
weight loss in some patients was possibly due to the
joined effect of the cancer’s aggression, the cancer treat-
ments and emotional factors, such as depression and
unwillingness to be PEG-fed31,32. In spite of being
gastrostomized, and thus having a backup feeding suply,
some patients were reluctant to being tube fed, and went
on having a food intake below their needs.
Weight loss prevalence in our sample was lower to
the one detected by other groups of patients with head
or neck cancer (70%) due to the fact of our patients
being gastrostomized, to have an alternate feeding
system24,33,34. Severely undernourished patients (PG-
SGA C) had a higher average weight loss percentage,
followed by those who were moderately undernou-
rished (PG-SGA B) and those who were well-
nourished (PG-SGA A). Likewise, due to being at an
advanced stage of nutritional status deterioration, the
benefits of nutritional intervention in severely under-
nourished patients are, as mentioned by other authors,
limited35. So, it is important to identify symptoms
related to a pre-cachexia phase and to initiate tube
feeding sooner on patients with higher risk of undernu-
trition, before the treatment, to prevent weight loss and
the patient’s nutritional status decay5,35. Tube feeding
has allowed for appropriate food intake, and thus the
maintenance or body weight gain in 21 patients (50%),
fulfilling the intended purpose of maintaining or increa -
sing body weight5,8.
In our study, the reasons pointed out by the patients
that were relevant for decreased food intake or nutrient
absorption were constipation, anorexia, early satiation,
nausea, vomiting and diarrhea, all symptoms common
in cancer patients, as pointed out by other authors6,34. In
another study with patients with head or neck cancer,
the most frequent symptoms were dysphagia, due to the
harmful location of the tumors, and pain, which affected
food intake, which were not relevant complaints from
our patients, due to the PEG feeding option29.
Most patients presented some degree of functional
deficit in the month before the PG-SGA study, with 25
patients (59,5%) presenting moderate or severe func-
tional deficit.
As expected, severely undernourished patients (PG-
SGA C) were the ones that had a higher average total
PG-SGA score, followed by those moderately under-
nourished (AGS-GD B) and those well-nourished (PG-
SGA A). In our sample, like in other studies, patients
with PG-SGA scores of 0-1 (no need for treatment or
nutritional intervention) were rare25.
Looking at the laboratory data, severely undernou-
rished patients (PG-SGA C) were the ones that presented
lower average serum albumin and transferrin levels,
followed by those moderately undernourished (PG-SGA
B) and those well-nourished (PG-SGA A). Statistically
significant differences were found in our study between
the average serum albumin and transferrin levels in well-
nourished (PG-SGA A) and moderately and severely
undernourished patients (PG- SGA B+C)20,21,24. An asso-
ciation was found, in our study, between the nutritional
status assessment using the PG-SGA and the serum
albumin and transferrin levels in cancer patients subject
to prolonged tube feeding. Although in many clinical
settings serum albumin and transferrin levels may reflect
inflammatory status, the close relation between the PG-
SGA and the serum proteins suggests that low albumin
and transferrin are biomarkers of malnutrition in our head
or neck cancer patients2,11,12,14.
Conclusions
In our experience with PEG fed head or neck cancer
patients, PG-SGA was a practicable tool for nutritional
status evaluation, even in patients with impaired spea-
king skills. PG-SGA was a useful tool in classifying
most (25/42) of the patients as PG-SGA B or C, with
moderate/severe malnutrition. Scored-PG-SGA rated
41 out of 42 with scores ≥ 2, thus identifying the need
for nutritional or pharmacological intervention.
Scored-PG-SGA should be systematically included in
the evaluation of head or neck cancer PEG fed patients,
even in those with speech difficulties. Although cancer
patients may have low grade systemic inflammation, in
our patients, serum albumin and transferrin showed a
relation with PG-SGA and should be considered as
nutritional biomarkers.
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